Prof. Boyoung Park | Epidemiology | Best Researcher Award

Prof. Boyoung Park, Hanyang University College of Medicine, South Korea

Professor Boyoung Park is a distinguished expert in preventive medicine, currently serving at Hanyang University College of Medicine in Seoul, South Korea. She leads the Bio-Big Data Center at the Hanyang Institute of Bioscience and Biotechnology. Her research, focusing on breast cancer risk factors and epidemiology, has been published in reputable journals such as the British Journal of Cancer and BMJ Open. In 2023, she was honored with the Kwangdong Cancer Academic Award by the Korean Cancer Association. Additionally, she contributes to the academic community as a senior editor for the Journal of Preventive Medicine & Public Health.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Professor Boyoung Park embarked on her medical education at the Catholic University of Daegu, where she earned her M.D. in 2006. Her passion for preventive medicine led her to Seoul National University College of Medicine, where she obtained her M.S. in 2010 and subsequently completed her Ph.D. in 2012. This strong academic foundation set the stage for her future contributions to epidemiology and cancer research.

💼 PROFESSIONAL ENDEAVORS:

Prof. Park’s career trajectory has been marked by prestigious positions in both academia and research institutions:

• Director of the Bio-BigData Center at the Hanyang Institute of Bioscience and Biotechnology (2024–present)
• Professor at the Department of Preventive Medicine, Hanyang University College of Medicine (2023–present)
• Associate Professor at Hanyang University College of Medicine (2018–2023)
• Assistant Professor at the National Cancer Center Graduate School of Cancer Science and Policy (2015–2018)
• Associate Scientist at the National Cancer Control Institute, National Cancer Center (2012–2018)
• Fellowship at the National Cancer Control Institute, National Cancer Center (2011–2012)
• Residency in Preventive Medicine at Seoul National University College of Medicine (2008–2011)
• Internship at Asan Medical Center, Seoul (2006–2007)

Her experience spans clinical practice, research, and academic leadership, demonstrating her commitment to advancing public health and epidemiology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON EPIDEMIOLOGY:

Prof. Park has played a crucial role in cancer epidemiology, HIV research, and the development of disease risk assessment models. Her research interests include:

• Cancer prevention and control
• HIV/AIDS and chronic infectious diseases
• Big data and epidemiological studies
• Genome analysis and risk assessment models

🏆 RESEARCH GRANTS:

She has led multiple nationally funded projects, including:

• Korea HIV/AIDS Cohort Study (2023–2024) – Principal Investigator
• Korea Atomic Bomb Survivors Cohort and Genome Analysis (2020–2024) – Principal Investigator
• Development of a Breast Cancer Risk Assessment Model (2021–2025) – Principal Investigator
• Transfusion and Prognosis in Hepatobiliary & Pancreatic Surgery (2022–2025) – Principal Investigator

🏅 IMPACT AND INFLUENCE:

Prof. Park’s work has been widely recognized through prestigious awards and honors, such as:

• National AIDS and STI Contributor Award (2023) – Korea Disease Control and Prevention Agency
• Kwangdong Cancer Academic Award (2023) – Korean Cancer Association
• Outstanding Paper Review Committee Award (2022) – Korean Society of Epidemiology
• Excellent Researcher Award (2021) – Hanyang University
• Young Epidemiologist Award (2015) – Korean Society of Epidemiology

📖 ACADEMIC CITATIONS AND EDITORIAL CONTRIBUTIONS:

Prof. Park serves as a Senior Editor and Editorial Board Member for leading medical journals:

• Journal of Preventive Medicine & Public Health (Senior Editor)
• Cancer Research and Treatment (Editorial Board Member)
• Journal of Cancer Prevention (Editorial Board Member)

Her contributions to medical literature have significantly shaped the fields of epidemiology and public health.

🔮 LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Boyoung Park has established herself as a leading figure in preventive medicine and cancer epidemiology. Moving forward, she aims to:
 Advance big data-driven epidemiological research
Enhance public health policies for cancer prevention
Develop personalized risk assessment models for chronic diseases
Strengthen national and global health collaborations

Her groundbreaking work continues to shape the future of epidemiology, public health, and medical research in South Korea and beyond.

🌍CONCLUSION: